RU97106477A - METHOD FOR PATHOGENETIC TREATMENT OF VIRAL HEPATITIS - Google Patents

METHOD FOR PATHOGENETIC TREATMENT OF VIRAL HEPATITIS

Info

Publication number
RU97106477A
RU97106477A RU97106477/14A RU97106477A RU97106477A RU 97106477 A RU97106477 A RU 97106477A RU 97106477/14 A RU97106477/14 A RU 97106477/14A RU 97106477 A RU97106477 A RU 97106477A RU 97106477 A RU97106477 A RU 97106477A
Authority
RU
Russia
Prior art keywords
viral hepatitis
pathogenetic treatment
pathogenetic
treatment
immunoproductive
Prior art date
Application number
RU97106477/14A
Other languages
Russian (ru)
Inventor
И.М. Мельцер
Б.М. Кершенгольц
М.Н. Алексеева
Original Assignee
Якутский государственный университет
Filing date
Publication date
Application filed by Якутский государственный университет filed Critical Якутский государственный университет
Publication of RU97106477A publication Critical patent/RU97106477A/en

Links

Claims (1)

Способ патогенетического лечения вирусных гепатитов, включающий применение препаратов, оказывающих влияние на реактивность иммунной системы, отличающийся тем, что используется комплексный, сбалансированный по всем основным группам иммунорегуляторов биофармпрепарат иммунокоррегирующего действия "Эпсорин", путем перорального введения индивидуально подбираемых доз, необходимых для формирования в организме больного фазы неспецифической адаптивной реакции "устойчивая активация".A method for the pathogenetic treatment of viral hepatitis, including the use of drugs that affect the responsiveness of the immune system, characterized in that a comprehensive, balanced for all major groups of immunoregulators immunoproductive action "Epsorin" is used, by oral administration of individually selected doses necessary for the formation in the patient's body phases of the non-specific adaptive reaction "sustained activation".
RU97106477/14A 1997-04-17 METHOD FOR PATHOGENETIC TREATMENT OF VIRAL HEPATITIS RU97106477A (en)

Publications (1)

Publication Number Publication Date
RU97106477A true RU97106477A (en) 1999-05-10

Family

ID=

Similar Documents

Publication Publication Date Title
CA2288038A1 (en) Polyethylene glycol-interferon alpha conjugates for therapy of infection
EP1946775A3 (en) Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody
EP1808434A3 (en) Use of 5-fluoro-2'-deoxy-3'-thiacytidine fo the treatment of hepatitis B
CA2149329A1 (en) Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma
DE68908786D1 (en) Condensed pyrimidine derivatives, processes and intermediates for their preparation and pharmaceutical preparations containing them.
DE68913831D1 (en) Condensed pyrimidine derivatives, processes and intermediates for their preparation and pharmaceutical preparations containing them.
ITMI931522A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION (HBV)
DK92788A (en) USE OF 3'-DEOXY-3'-FLUORUANOSIDES FOR THE PREPARATION OF MEDICINAL PRODUCTS AGAINST RETROVIRA
DE69431665D1 (en) PEPTIDES FOR INDUCING A RESPONSE OF THE CYTOTOXIC T-LYMPHOCYTHES TARGETED AGAINST THE HEPATITIS B-VIRUS
DK0859957T3 (en) Patient-specific immunosorbents for extraporal apheresis and methods for their preparation
IT8619055A0 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING PEPTIDES OF THE CHOLECYSTOKININ-CERULIN GROUP FOR THE THERAPEUTIC TREATMENT OF SHOCK STATES AND RESPIRATORY AND CARDIOCIRCULAR INSUFFICIENCY.
ATE320444T1 (en) PEPTIDES THAT INDUCE THE CYTOTOXIC T-LYMPHOCYTE RESPONSE AGAINST HEPATITIS B VIRUS
DE60123042D1 (en) L-FMAU FOR THE TREATMENT OF HEPATITIS DELTA VIRUS INFICATION
RU97106477A (en) METHOD FOR PATHOGENETIC TREATMENT OF VIRAL HEPATITIS
EA199800770A1 (en) DRUGS FOR THERAPEUTIC TREATMENT OF VIRAL HEPATITIS
IT1276509B1 (en) VACCINE FOR THE IMMUNE PROPHYLAXY OF FELINE IMMUNODEFICIENCY VIRUS INFECTION OF DOMESTIC CAT.
GR3021983T3 (en) Cross-reactive influenza a immunization
IT8221787A0 (en) PROCEDURE FOR THE PREPARATION OF PURE HEPATITIS B SURFACE ANTIGEN FROM HUMAN PLASMA.
FR2635977B1 (en) USE OF TETRAHYDRO-4,5,6,7 FUROPYRIDINES DERIVATIVES FOR OBTAINING MEDICINES FOR THE TREATMENT OF OBESITY
EP0362755A3 (en) Human cytotoxic t-cell clone and antibody thereto
EP0240366A3 (en) Perhydrothiazepine and perhydroazepine derivatives, their preparation and their therapeutic use
James New information on HIV rapid turnover--what does it mean?
NO166789C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CALCIUM-10-PROPYL-2,8-BIS (1H-TETRAZOL-5-YL) -4H, 6H-BENZO (1,2-B; 5,4-B ') DI-PYRANE 4,6-dione.
AU2065488A (en) The preparation of antigens of human immunodeficiency virus type 1, and the use thereof as diagnostic and therapeutic agent
FR2734821B1 (en) 5-METHOXYMETHYL-3- (1,2-BENZISOXAZOL-3-YL) OXAZOLIDIN-2-ONE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION